The clearest signal from trading in Cairo on Sunday, August 9, 2026 did not come from banks or property developers. It came from pharmaceuticals. Egyptian International Pharmaceutical Industries absorbed EGP 538.0 million in turnover and rose 2.6% to EGP 133.49, comfortably ahead of the EGX 30 index, which added 0.82% to 55,125.4. With USD/EGP still trading at 49.75, that outperformance matters: it points to investor demand for defensive earnings streams and for companies seen as better able to pass through cost pressure.
Key figures
- EGX 30: 55,125.4, up 0.82%
- PHAR: +2.6% to EGP 133.49
- PHAR turnover: EGP 538.0 million
- Market breadth: 27 gainers, 12 losers, 5 unchanged
- USD/EGP: 49.75, up 0.19%
Egyptian stock exchange today: a rising index, but sector rotation tells the real story
The Cairo stock market posted a constructive session on the surface, with 27 stocks up, 12 down and 5 unchanged out of tracked names. That positive breadth confirms the rise in the benchmark was not driven by a single heavyweight. But the composition of the move is more revealing than the headline index print. Leadership came from fintech, industrials, healthcare and selected consumer names rather than from the more rate-sensitive corners of the market.